Oxford BioDynamics (LSE:OBD) Cash And Cash Equivalents : £5.25 Mil (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Cash And Cash Equivalents?

Oxford BioDynamics's quarterly cash and cash equivalents increased from Sep. 2022 (£0.97 Mil) to Mar. 2023 (£1.20 Mil) and increased from Mar. 2023 (£1.20 Mil) to Sep. 2023 (£5.25 Mil).

Oxford BioDynamics's annual cash and cash equivalents declined from Sep. 2021 (£2.18 Mil) to Sep. 2022 (£0.97 Mil) but then increased from Sep. 2022 (£0.97 Mil) to Sep. 2023 (£5.25 Mil).

Oxford BioDynamics Cash And Cash Equivalents Historical Data

The historical data trend for Oxford BioDynamics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Cash And Cash Equivalents Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Cash And Cash Equivalents

Get a 7-Day Free Trial

5.20

6.12

2.18

0.97

5.25

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial														2.18	2.95	0.97	1.20	5.25

Oxford BioDynamics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Oxford BioDynamics (LSE:OBD) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Oxford BioDynamics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (LSE:OBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

OXBOF:USA

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines